Mode
Text Size
Log in / Sign up

Patient Questions

Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.

Oncology

Are there links between paraganglioma and thyroid cancer lymph node spread?

Some inherited gene mutations can raise the risk of both paraganglioma and thyroid cancer, but the sources do not show that paraganglioma directly causes thyroid cancer lymph…

Oncology

What is the risk of metastasis for patients with the SDHD mutation and paraganglioma?

For people with an SDHD mutation who develop paraganglioma, the risk of metastasis appears to be low, around 4% in one meta-analysis, much lower than for SDHB mutations [6].

Oncology

What is the prevalence of CLDN18.2 expression in gastric adenocarcinoma patients?

CLDN18.2 is found in roughly 30% to 34% of gastric adenocarcinoma patients when using the stricter clinical cutoff, though rates vary by threshold and population [4][6].

Oncology

Does combining chemotherapy and immune checkpoint inhibitors improve response in gastric adenocarcinoma?

Yes. Adding immune checkpoint inhibitors to chemotherapy improves pathological response rates in gastric adenocarcinoma, though the survival benefit is less consistent.

Oncology

Can fluorescence-guided imaging be used to find neoplasms in veterinary medicine?

Yes. Fluorescence-guided imaging is already used in veterinary surgical oncology to help find and remove tumors, though it is not perfect and can miss or falsely flag tissue…

Oncology

How does the CXCL16/CXCR6 axis affect the growth of neoplasms?

The CXCL16/CXCR6 axis acts as a "double-edged sword" in cancer, where it can either promote tumor growth and drug resistance or be targeted to inhibit tumor progression.

Oncology

Can the drugs pazopanib and axitinib cause cholecystitis in cancer patients?

A single case report links pazopanib and axitinib to probable cholecystitis in a kidney cancer patient, but this is rare and based on limited evidence [1].

Oncology

Can molecular markers improve over traditional grading for oral potentially malignant disorders?

Molecular markers may improve risk assessment for oral potentially malignant disorders (OPMD) because traditional grading based on tissue appearance can be unreliable due to the…

Oncology

Are molecular markers better for assessing risk in oral potentially malignant disorders?

Molecular markers show promise for improving risk assessment in oral potentially malignant disorders, but they are not yet proven better than standard histopathology and need…

Oncology

What are the outcomes for patients with relapsed Wilms tumor in the UK?

A UK trial for relapsed Wilms tumor reported a 63% four-year event-free survival rate and a 68% overall survival rate.

Oncology

Can an epithelial-type Wilms tumor be treated with surgery?

Surgery is a standard treatment for epithelial-type Wilms tumor in both children and adults.

Oncology

Can a Wilms tumor occur in an adult woman?

While Wilms tumor is primarily a childhood cancer, it can occur in adult women, though these cases are extremely rare.

Oncology

Can a Wilms tumor return many years after the initial diagnosis?

While rare, Wilms tumor can recur many years after the initial diagnosis, with one documented case occurring 32 years after the first diagnosis.

Oncology

Does pucotenlimab show improved outcomes for patients with gastroesophageal junction cancer?

Yes, pucotenlimab shows improved outcomes for gastroesophageal junction cancer, especially when combined with oxaliplatin/capecitabine, though evidence is based on a…

Oncology

What are the results of pembrolizumab plus chemotherapy for HER2-negative gastroesophageal junction cancer?

Pembrolizumab plus chemotherapy improves overall survival, progression-free survival, and response rates in HER2-negative gastroesophageal junction cancer, with manageable…

Oncology

Is the combination of ASTX727 and talazoparib being tested for HER2-negative Breast Cancer?

A phase 1 trial is testing the combination of ASTX727 and talazoparib for triple-negative metastatic breast cancer and hormone-resistant breast cancer.

Oncology

Are there clinical trials for CAR T-cell therapy in pediatric Medulloblastoma?

While CAR T-cell therapy is currently being explored for pediatric brain tumors like medulloblastoma, most evidence for its effectiveness comes from preclinical studies or…

Oncology

What role does HPV play in the development of oropharyngeal squamous cell carcinoma?

HPV, especially type 16, drives most oropharyngeal squamous cell carcinomas through E6/E7 oncoproteins, which disable key tumor suppressors and lead to distinct, often more…

Oncology

Do modern radiotherapy protocols improve symptoms for those with oropharyngeal squamous cell carcinoma?

Modern radiotherapy protocols for oropharyngeal squamous cell carcinoma have shown improvements in patient-reported outcomes, including fewer symptoms and lower levels of anxiety…

Oncology

Does laparoscopic surgery for Liver Cancer result in better quality of life?

Laparoscopic liver surgery generally offers a faster recovery and fewer complications than open surgery, which can improve quality of life, though long-term survival is similar.

Oncology

Are there new combination strategies for treating tumors like Liver Cancer?

Yes, new combination strategies for liver cancer are emerging, including immunotherapy with anti-angiogenic drugs, and surgical techniques like hepatic vein occlusion with portal…

Oncology

Is there a higher recurrence rate with hemithyroidectomy for differentiated thyroid cancer?

Yes, hemithyroidectomy is associated with a higher recurrence rate for differentiated thyroid cancer, with a 3% absolute risk increase compared to total thyroidectomy.

Oncology

Does TSH suppression therapy cause tumor progression in differentiated thyroid cancer?

TSH suppression therapy is used to control and slow the progression of differentiated thyroid cancer by preventing the hormone from stimulating tumor growth.

Oncology

Does a hemithyroidectomy increase the risk of recurrence in differentiated thyroid cancer?

Hemithyroidectomy is linked to a slightly higher recurrence risk (about 3% absolute increase) compared to total thyroidectomy, but for low-risk patients the difference is small…

How this works

We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.

This is not medical advice. Always speak with your own doctor before making decisions about your health.